Vanguard Portfolio Management’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
Other funds holding LUNG
SCM
ECM
AC
SCM
B
Vanguard Portfolio Management's LUNG Position: Q2 2026 in Review
Vanguard Portfolio Management sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 604,455 shares — an estimated $780K sold.
Vanguard Portfolio Management first reported a position in LUNG in Q1 2026 and held it in 1 quarter. The position peaked at $780K in Q1 2026. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.
- Vanguard Portfolio Management reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
- Vanguard Portfolio Management sold 604,455 Pulmonx shares in Q2 2026, an estimated $780K.
- Vanguard Portfolio Management first reported a position in Pulmonx in Q1 2026 and held it in 1 quarter.
- Vanguard Portfolio Management's Pulmonx position peaked at $780K in Q1 2026.
- 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.